EFC (I) Financial Statement Analysis
|
||
|
The Revenues of EFC (I) have increased by 306.40% YoY .
The Earnings Per Share (EPS) of EFC (I) has decreased by -2.75 % YoY. |
||
EFC (I) Last 5 Annual Financial Results
[BOM: 512008|NSE : EFCIL]
| Consolidated | Mar2025 | Mar2024 | Mar2023 | Mar2022 |
|---|---|---|---|---|
| Operating Income | ₹419 Cr | ₹103 Cr | ₹0.00 Cr | ₹0.00 Cr |
| Operating Expenses | ₹91 Cr | ₹28 Cr | ₹0.00 Cr | ₹0.00 Cr |
| Expenses | ₹237 Cr | ₹48 Cr | ₹0.09 Cr | ₹0.09 Cr |
| Operating Profit (Excl OI) | ₹183 Cr | ₹55 Cr | ₹-0.09 Cr | ₹-0.09 Cr |
| Other Income | ₹9.32 Cr | ₹0.85 Cr | ₹0.11 Cr | ₹0.11 Cr |
| Interest | ₹35 Cr | ₹15 Cr | ₹0.00 Cr | ₹0.00 Cr |
| Depreciation | ₹76 Cr | ₹34 Cr | ₹0.00 Cr | ₹0.00 Cr |
| Profit Before Tax | ₹81 Cr | ₹7.19 Cr | ₹0.02 Cr | ₹0.02 Cr |
| Profit After Tax | ₹63 Cr | ₹3.86 Cr | ₹0.01 Cr | ₹0.01 Cr |
| Consolidated Net Profit | ₹58 Cr | ₹4.34 Cr | ₹0.01 Cr | ₹0.01 Cr |
| Earnings Per Share (Rs) | ₹11.33 | ₹11.65 | ₹6.35 | ₹0.18 |
| PAT Margin (%) | 21.44 | 15.09 | 3.74 | 0.00 |
| ROE(%) | 29.03 | 25.47 | 10.73 | 0.76 |
| ROCE(%) | 37.32 | 34.56 | 32.82 | 1.17 |
| Total Debt/Equity(x) | 0.43 | 0.27 | 0.83 | 0.00 |
Key Financials |
||
| Market Cap | : | ₹ 3,020.9 Cr |
| Revenue (TTM) | : | ₹ 1,036.7 Cr |
| Net Profit(TTM) | : | ₹ 234.7 Cr |
| EPS (TTM) | : | ₹ 15.9 |
| P/E (TTM) | : | 12.9 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| EFC (I) | 10.7% | 15.1% | -38.6% |
| SAGILITY | 4% | 1.8% | -1.2% |
| SYNGENE INTERNATIONAL | 1.6% | 0.4% | -31.9% |
| PRIME FOCUS | 11.1% | 4.4% | 112.8% |
| INTERNATIONAL GEMOLOGICAL INSTITUTE | 2.6% | 0% | 0.5% |
| INDEGENE | -1.5% | -2% | -10.5% |
| NESCO | 3% | -3% | -0.3% |
| LATENT VIEW ANALYTICS | 0.1% | -10.9% | -31.6% |
| SUN PHARMA ADVANCED RESEARCH COMPANY | 3.3% | 14.9% | 49.8% |
EFC (I) Revenues
[BOM: 512008|NSE : EFCIL]
| Y-o-Y | 306.40 % |
| 5 Yr CAGR | 0 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2025 | ₹419 Cr | 306.40 | |
| Mar2024 | ₹103 Cr | 0 | |
| Mar2023 | ₹0.00 Cr | 0 | |
| Mar2022 | ₹0.00 Cr | - | |
EFC (I) Operating Profit
[BOM: 512008|NSE : EFCIL]
| Y-o-Y | 229.54 % |
| 5 Yr CAGR | Positive |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹183 Cr | 229.54 | |
| Mar2024 | ₹55 Cr | Positive | |
| Mar2023 | ₹-0.09 Cr | Negative | |
| Mar2022 | ₹-0.09 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | -18.92 % |
| 5 Yr CAGR | 0 |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2025 | 43.53% | -18.92 | |
| Mar2024 | 53.69% | 0 | |
| Mar2023 | 0% | 0 | |
| Mar2022 | 0% | - | |
EFC (I) Profit After Tax
[BOM: 512008|NSE : EFCIL]
| Y-o-Y | 1,236.61 % |
| 5 Yr CAGR | 1,546.08 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2025 | ₹58 Cr | 1,236.61 | |
| Mar2024 | ₹4.34 Cr | 33,269.23 | |
| Mar2023 | ₹0.01 Cr | 0.00 | |
| Mar2022 | ₹0.01 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | 42.08 % |
| 5 Yr CAGR | 0 |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2025 | 21.44 % | 42.08 | |
| Mar2024 | 15.09 % | 303.48 | |
| Mar2023 | 3.74 % | 0 | |
| Mar2022 | 0 % | - | |
EFC (I) Earnings Per Share (EPS)
[BOM: 512008|NSE : EFCIL]
| Y-o-Y | -2.75 % |
| 5 Yr CAGR | 297.79 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2025 | ₹11 | -2.75 | |
| Mar2024 | ₹12 | 83.46 | |
| Mar2023 | ₹6.35 | 3,427.78 | |
| Mar2022 | ₹0.18 | - | |
EFC (I) Return on Capital Employed (ROCE)
[BOM: 512008|NSE : EFCIL]
| Y-o-Y | 7.99 % |
| 5 Yr CAGR | 217.14 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2025 | 37.32% | 7.99 | |
| Mar2024 | 34.56% | 5.30 | |
| Mar2023 | 32.82% | 2,705.13 | |
| Mar2022 | 1.17% | - | |
EFC (I) Share Price vs Sensex
| Current Share Price | : | ₹204.3 |
| Current MarketCap | : | ₹ 3,020.9 Cr |
| Updated EOD on | : | Jul 03,2026 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EFC (I) | 10.7% |
15.1% |
-38.6% |
| SENSEX | 0.9% |
4.2% |
-6% |
EFC (I) related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| BSE SERVICES | 2.2% | 9.7% | 8.3% |
You may also like the below Video Courses
FAQ about EFC (I) Financials
How the annual revenues of EFC (I) have changed ?
The Revenues of EFC (I) have increased by 306.40% YoY .
How the Earnings per Share (EPS) of EFC (I) have changed?
The Earnings Per Share (EPS) of EFC (I) has decreased by -2.75 % YoY .
SAGILITY LTD vs SYNGENE INTERNATIONAL LTD vs PRIME FOCUS LTD
INTERNATIONAL GEMOLOGICAL INSTITUTE LTD vs INDEGENE LTD vs